NCT00871767View on ClinicalTrials.gov

AZD5672 Bioavailability Study in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

AZD5672

40 mg tablet (Test formulation)

DRUG

AZD5672

40 mg tablet (Reference formulation)

DRUG

AZD5672

100 mg tablet (Test formulation)

DRUG

AZD5672

100 mg (2 x 50 mg tablet (Reference Formulation)

Trial Locations (1)

Unknown

Research Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY